NYSE:SNV • US87161C5013
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SYNOVUS FINANCIAL CORP (SNV).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-12-19 | Barclays | Maintains | Overweight -> Overweight |
| 2025-12-16 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-11-11 | Barclays | Maintains | Overweight -> Overweight |
| 2025-11-05 | UBS | Maintains | Neutral -> Neutral |
| 2025-10-17 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-10-17 | Stephens & Co. | Maintains | Equal-Weight -> Equal-Weight |
| 2025-10-17 | Truist Securities | Maintains | Buy -> Buy |
| 2025-10-16 | DA Davidson | Maintains | Buy -> Buy |
| 2025-10-01 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-09-24 | Truist Securities | Maintains | Buy -> Buy |
| 2025-09-02 | UBS | Downgrade | Buy -> Neutral |
| 2025-08-13 | Keefe, Bruyette & Woods | Downgrade | Outperform -> Market Perform |
| 2025-07-29 | Stephens & Co. | Maintains | Equal-Weight -> Equal-Weight |
| 2025-07-28 | Barclays | Maintains | Overweight -> Overweight |
| 2025-07-25 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2025-07-18 | Keefe, Bruyette & Woods | Upgrade | Market Perform -> Outperform |
| 2025-07-18 | DA Davidson | Maintains | Buy -> Buy |
| 2025-07-18 | Raymond James | Upgrade | Market Perform -> Outperform |
| 2025-07-18 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-07-11 | Truist Securities | Maintains | Buy -> Buy |
| 2025-07-10 | Wells Fargo | Upgrade | Equal-Weight -> Overweight |
| 2025-07-08 | Barclays | Maintains | Overweight -> Overweight |
| 2025-07-01 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-05-21 | Jefferies | Initiate | Hold |
| 2025-05-13 | Truist Securities | Initiate | Buy |
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.206B 11.26% | 2.208B 0.06% | 1.989B -9.89% | 2.418B 21.56% | 2.538B 4.96% | 2.662B 4.89% | |
| EBITDA YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | N/A 18.31% | N/A -7.98% | N/A -0.43% | 1.101B 15.43% | 1.1B -0.09% | 1.18B 7.27% | |
| Operating Margin | N/A | N/A | N/A | 45.53% | 43.34% | 44.33% | |
| EPS YoY % growth | 4.94 -0.40% | 4.39 -11.13% | 4.50 2.51% | 5.68 26.29% | 5.68 -0.11% | 6.07 7.00% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.42 13.59% | 1.34 2.95% | 1.39 -6.03% | 1.44 -1.58% | 1.48 4.39% | 1.41 5.25% | 1.48 6.25% | 1.48 3.09% | 1.54 3.92% |
| Revenue Q2Q % growth | 619M 6.62% | 611.99M 7.21% | 626.66M 5.55% | 642.23M 4.36% | 651.2M 5.20% | 647.81M 5.85% | 662.18M 5.67% | 675.06M 5.11% | 681.2M 4.61% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 283.73M 12.15% | 264.4M 7.54% | 272.54M 1.40% | 282.05M 0.51% | 286.98M 1.15% | 293.91M 11.16% | 306.03M 12.29% | 316.13M 12.08% | 317.14M 10.51% |
All data in USD
19 analysts have analysed SNV and the average price target is 59.16 USD. This implies a price increase of 18.2% is expected in the next year compared to the current price of 50.05.
SYNOVUS FINANCIAL CORP (SNV) will report earnings on 2026-01-21, after the market close.
The consensus EPS estimate for the next earnings of SYNOVUS FINANCIAL CORP (SNV) is 1.42 USD and the consensus revenue estimate is 619.00M USD.
The consensus rating for SYNOVUS FINANCIAL CORP (SNV) is 74.7368 / 100 . This indicates that analysts generally have a positive outlook on the stock.